Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain
| Autor: | Jaime Rodríguez Quintosa, Cintia Cristina Ago, Antoni Sicras Mainar, Renata Villoro, Inés Pérez-Román |
|---|---|
| Jazyk: | English<br />Spanish; Castilian<br />Italian |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Global & Regional Health Technology Assessment, Vol 9, Iss 1 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2284-2403 2283-5733 |
| DOI: | 10.33393/grhta.2022.2439 |
| Popis: | Background: Impetigo is a common dermatological paediatric infection that can be treated with topical antibiotics: the common are mupirocin (MUP), fusidic acid (FA) and, most recently, ozenoxacin (OZ). Aim: This study assesses the clinical and economic consequences of the use of OZ vs. MUP and vs. FA for the treatment of impetigo in routine clinical practice in Spain. Methods: This is a retrospective observational study using real-life data from electronic medical records of patients with impetigo who started treatment with OZ, MUP or FA (maximum follow-up: 3 months; n = 10,974). We compared treatment duration, comorbidities, use of systemic medication, complications, utilization of resources and associated costs across treatments (p |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|